Benjamin Stecher was diagnosed with Parkinson's Disease aged twenty-nine and has since become actively involved in Parkinson's Disease research and advocacy. He is the founder of Tomorrow Edition, and sits on several patient advisory boards working to bring better therapies for people diagnosed with Parkinson's disease.
~~tag-text~~
An estimated 80 million people live with a neurodegenerative disease, with this number expected to double by 2050. Despite decades of research and billions in funding, there are no medications that can slow, much less stop, the progress of these diseases.... SEE MORE